Danny Kushlick, founder of the UK’s leading drug policy think tank Transform, will describe how the drug war has become an orthodoxy, through securitising cocaine. He will show how applying an evidence-based approach built upon humanity, effectiveness and justice, would lead to a system such as that outlined in Transform’s new book: ‘After the War on Drugs – Blueprint for Regulation’.
IDHDP will be hosting a session where policies on treating stimulant use, particularly crack cocaine, will feature along with what new thinking needs to take place to stem the terrible violence taking place in South American producer and transit countries.
The main goal of the conference is to advocate for and promote harm reduction in the countries of the MENA region and to foster networking between civil society organisations and other stakeholders working in the field.
Waterstones, 19-21 Tottenham Court Rd, London W1T 1BJ
Join Tom Wainwright, author of 'Narconomics', in a panel discussion on Latin America’s drug war, its human and financial costs, and how this impacts other countries.
The World Drug Report will be launched during a Special Event of the Commission on Narcotic Drugs (CND) on the International Day against Drug Abuse and Illicit Trafficking, chaired by Ambassador Mirghani Abbaker Altayeb Bakhet, Chair of the 62nd session of the CND.
This third webinar is aimed at discussing harm reduction services for non-injecting drug users and particularly people who use stimulant drugs in the time of COVID-19.
In this webinar, Transform Drug Policy Foundation introduces their proposals for the regulation of stimulants. In doing so, they will lay out a realistic alternative to the prohibition of stimulant drugs.
In this EHRN session, dedicated experts in the fields of harm reduction and drug policy will review and discuss the specific challenges therein, as laid out in the Harm Reduction Journal.
This report explores the FARC’s involvement in Colombia’s illegal drug trade, its alliances with other groups in the region and possible scenarios for the future.
While participants largely continue to use crack, the intensity of their use has dropped significantly. They have also benefited from a drastically increased quality of life as result of the housing and access to health care.
Welcome to the second edition of the IDPC Drug Policy Guide. The Guide brings together global evidence and examples of best practice to provide guidance on the review, design and implementation of national drug policies.
This paper summarises data for the prevalence, correlates, and probable adverse health consequences of problem use of amphetamines, cannabis, cocaine, and opioids. We discuss findings from systematic reviews of the prevalence of illicit drug use and dependence, remission from dependence, and…
The report consists of a summary of the national drug situation presenting brief information in key areas (drugs prevalence, prevention, harm reduction, drug laws etc.).
This EMCDDA Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented.
